Home 9 Neurology 9 All Videos For Neurology 9 Motor Symptoms and Therapy Choices – Advanced Parkinson’s Disease

Motor Symptoms and Therapy Choices – Advanced Parkinson’s Disease

November 30, 2020

An exclusive panel discussion, featuring the following industry leading experts: Bas Bloem, MD, PhD; Per Odin MD, PhD & Olivier Rascol, MD, PhD

CME ACCREDITED – The European Accreditation Committee in CNS (EACIC) has granted 1 (one) CME credit to this online programme. To obtain your CME credits, complete the evaluation form at www.eacic.eu.

This e-Roundtable discussion was supported and funded by Britannia Pharmaceuticals Limited

HOW TO OBTAIN CME CREDITS

Participants requesting CME credits are required to complete the online evaluation form on the EACIC website www.eacic.eu.

Please follow the below steps to receive your CME Certificate.

Go to the EACIC website www.eacic.eu

  1. Click on “CLAIM YOUR CME CREDITS
  2. Choose the option “I AM ALREADY REGISTERED” or “I AM NOT REGISTERED
  3. The Event Code for this event is ORUEN2020
  4. Log on or register
  5. Complete the online evaluation form
  6. Press “save”
  7. Your CME certificate will be automatically emailed to the address provided

The deadline to complete the evaluation form is 30 April 2021.

APO-go® Apomorphine hydrochloride is indicated for the treatment of motor fluctuations (“on-off” phenomena) in patients with Parkinson’s disease which are not sufficiently controlled by an oral anti-Parkinson medication. Click here for Prescribing information
Adverse events should be reported. Reporting forms and information. can be found at mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should be reported to Britannia Pharmaceuticals Ltd at dso@britannia-pharm.com or 01483 920 763.

 

Job Code: GL-APO-2000003                               Date of Preparation: November 2020

0 Comments

Newsletter

Keep up to date with our latest
articles and journals